Gene therapy for severe combined immunodeficiency: are we there yet?
J. Clin. Invest. Marina Cavazzana-Calvo, et al. 117:1456 doi:10.1172/JCI30953 [Go to this article.]

Figure 1
Cumulative probability of survival in SCID patients after HSCT according to donor-recipient compatibility. Figure reproduced with permission from The Lancet (6).